These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8957160)

  • 1. Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium.
    Spencer CM; Goa KL
    Drugs; 1996 Dec; 52(6):899-927. PubMed ID: 8957160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, tolerance, and pharmacokinetics of iodixanol injection, a nonionic, isosmolar, hexa-iodinated contrast agent.
    Fountaine H; Harnish P; Andrew E; Grynne B
    Acad Radiol; 1996 Sep; 3 Suppl 3():S475-84. PubMed ID: 8883524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of iodixanol on renal function immediately after abdominal angiography. Clinical comparison with iomeprol and ioxaglate.
    Murakami R; Tajima H; Kumazaki T; Yamamoto K
    Acta Radiol; 1998 Jul; 39(4):368-71. PubMed ID: 9685820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators.
    Bertrand ME; Esplugas E; Piessens J; Rasch W
    Circulation; 2000 Jan; 101(2):131-6. PubMed ID: 10637198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal contrast agents for vascular imaging on computed tomography: iodixanol versus iohexol.
    Pannu HK; Thompson RE; Phelps J; Magee CA; Fishman EK
    Acad Radiol; 2005 May; 12(5):576-84. PubMed ID: 15866130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of iodinated contrast agent properties on renal kinetics and oxygenation.
    Lenhard DC; Frisk AL; Lengsfeld P; Pietsch H; Jost G
    Invest Radiol; 2013 Apr; 48(4):175-82. PubMed ID: 23262792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of low and isoosmolar contrast media on renal hemodynamic in a normal and ischemic dog kidney.
    Deray G; Bagnis C; Jacquiaud C; Dubois M; Adabra Y; Jaudon C
    Invest Radiol; 1999 Jan; 34(1):1-4. PubMed ID: 9888047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
    Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
    J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial.
    Tomsick TA; Foster LD; Liebeskind DS; Hill MD; Carrozella J; Goyal M; von Kummer R; Demchuk AM; Dzialowski I; Puetz V; Jovin T; Morales H; Palesch YY; Broderick J; Khatri P; Yeatts SD;
    AJNR Am J Neuroradiol; 2015 Nov; 36(11):2074-81. PubMed ID: 26228892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography.
    Palmers Y; De Greef D; Grynne BH; Smits J; Put E
    Eur J Radiol; 1993 Nov; 17(3):203-9. PubMed ID: 8293750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Iodixanol. A new isotonic x-ray contrast medium].
    Nossen JO; Andrew E; Aakhus T; Berg KJ; Jørgensen NP
    Tidsskr Nor Laegeforen; 1991 Apr; 111(9):1108-11. PubMed ID: 2024256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
    Mehran R; Nikolsky E; Kirtane AJ; Caixeta A; Wong SC; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Kim YH; Fahy M; Dangas GD
    JACC Cardiovasc Interv; 2009 May; 2(5):415-21. PubMed ID: 19463464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodixanol versus Iopromide at Coronary CT Angiography: Lumen Opacification and Effect on Heart Rhythm-the Randomized IsoCOR Trial.
    Lubbers MM; Kock M; Niezen A; Galema T; Kofflard M; Bruning T; Kooij HS; van Valen H; Dijkshoorn M; Booij R; Padmos A; Vogels A; Budde RPJ; Nieman K
    Radiology; 2018 Jan; 286(1):71-80. PubMed ID: 28809582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal safety of iodixanol.
    McCullough PA
    Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):655-61. PubMed ID: 17081087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.
    Zhang BC; Wu Q; Wang C; Li DY; Wang ZR
    J Cardiol; 2014 Apr; 63(4):260-8. PubMed ID: 24397991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
    Heinrich MC; Häberle L; Müller V; Bautz W; Uder M
    Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized comparison of iodixanol and iohexol in adult intracranial computed tomography scanning.
    Grossman RI; Modic MT
    Acad Radiol; 1996 Sep; 3 Suppl 3():S488-94. PubMed ID: 8883526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nonionic contrast media on the blood-brain barrier. Osmolality versus chemotoxicity.
    Wilson AJ; Evill CA; Sage MR
    Invest Radiol; 1991 Dec; 26(12):1091-4. PubMed ID: 1765444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml.
    Tveit K; Bolz KD; Bolstad B; Haugland T; Berg KJ; Skjaerpe T; Kloster YF
    Acta Radiol; 1994 Nov; 35(6):614-8. PubMed ID: 7946687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.